ZENTALIS PHARMACEUTICALS, INC. <ZNTL.O>: LEERINK PARTNERS ASSUMES COVERAGE WITH OUTPERFORM VS MARKET PERFORM RATING; TARGET PRICE $8 VS $4

Reuters2026/10/05 10:07

By:Reuters

ZENTALIS PHARMACEUTICALS, INC. : LEERINK PARTNERS ASSUMES COVERAGE WITH OUTPERFORM VS MARKET PERFORM RATING; TARGET PRICE $8 VS $4

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Target Hospitality 3Q Rev $129.1M >TH

Dow Jones•2026/11/09 11:45

Barrick Mining 3Q Copper Production 50,000 Tons >ABX.T

Dow Jones•2026/11/09 11:00

Barrick Mining 3Q EPS 80c >ABX.T

Dow Jones•2026/11/09 11:00

Nifty 50 Is Still Down 4.91% in 2026, So Why Does Citi See 13% Upside?

BeInCrypto•2026/11/09 08:24